Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery

被引:113
|
作者
Moghaddam, Seyyed Pouya Hadipour [1 ,2 ]
Yazdimamaghani, Mostafa [1 ,2 ]
Ghandehari, Hamidreza [1 ,2 ,3 ]
机构
[1] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA
[2] Univ Utah, Nano Inst Utah, Utah Ctr Nanomed, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA
关键词
Tunable; Structural difference; Hollow mesoporous silica nanoparticles; GSH-sensitive; Degradable; High loading capacity; BRIDGED SILSESQUIOXANE NANOPARTICLES; LYSOSOMAL THIOL REDUCTASE; IN-VITRO; ORGANOSILICA NANOPARTICLES; THERAPY; CELLS; VIVO; PLATFORM; PATHWAY; AGENTS;
D O I
10.1016/j.jconrel.2018.04.032
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Tunable glutathione (GSH)-sensitive hollow mesoporous silica nanoparticles (HMSiO2 NPs) were developed using a structural difference-based selective etching strategy. These organosilica hollow nanoparticles contained disulfide linkages (S-S) in the outer shell which were degraded by GSH. The particles were compared with their nonGSH-sensitive tetraethyl orthosilicate (TEOS) HMSiO2 counterparts in terms of their synthesis method, characterization, doxorubicin (DOX) release profile, and in vitro cytotoxicity in MCF-7 breast cancer cells. Transmission electron microscopy (TEM) of the particles indicated that the fabricated HMSiO2 NPs had an average diameter of 130 +/- 5 nm. Thermogravimetric analysis (TGA) revealed that GSH-sensitive particles had approximately 5.3% more weight loss than TEOS HMSiO2 NPs. Zeta potential of these redox-responsive particles was -23 +/- 1 mV at pH 6 in deionized (DI) water. Nitrogen adsorption-desorption isotherm revealed that the surface area of the hollow mesoporous nanoreservoirs was roughly 446 +/- 6 m(2) g(-1) and the average diameter of the pores was 2.3 +/- 0.5 nm. TEM images suggest that the nanoparticles started to lose mass integrity from Day 1. The particles showed a high loading capacity for DOX (8.9 +/- 0.5%) as a model drug, due to the large voids existing in the hollow structures. Approximately 58% of the incorporated DOX released within 14 days in phosphate buffered saline (PBS) at pH 6 and in the presence of 10mM of GSH, mimicking intracellular tumor microenvironment while release from TEOS HMSiO2 NPs was only c.a. 18%. The uptake of these hollow nanospheres by MCF-7 cells and RAW 264.7 macrophages was evaluated using TEM and confocal microscopy. The nanospheres were shown to accumulate in the endolysosomal compartments after incubation for 24 h with the maximum uptake of c.a. 2.1 +/- 0.3% and 5.2 +/- 0.4%, respectively. Cytotoxicity of the nanospheres was investigated using CCK-8 assay. Results indicate that intact hollow particles (both GSH-sensitive and TEOS HMSiO2 NPs) were nontoxic to MCF-7 cells after incubation for 24 h within the concentration range of 0-1000 mu g ml(-1). DOX-loaded GSH-sensitive nanospheres containing 6 mu g ml(-1) of DOX killed c.a. 51% of MCF-7 cells after 24 h while TEOS HMSiO2 NPs killed c. a. 20% with the difference being statistically significant. Finally, cytotoxicity data in RAW 264.7 macrophages and NIH 3T3 fibroblasts shows that intact GSH-sensitive HMSiO2 NPs did not show any toxic effects on these cells with the concentrations equal or < 125 mu g ml(-1).
引用
收藏
页码:62 / 75
页数:14
相关论文
共 50 条
  • [21] Mixed shell mesoporous silica nanoparticles for controlled drug encapsulation and delivery
    Wu, Qiuhua
    Hou, Yu
    Han, Guangxi
    Liu, Xue
    Tang, Xiuping
    Li, Hong
    Song, Ximing
    Zhang, Guolin
    NANOMEDICINE, 2017, 12 (22) : 2699 - 2711
  • [22] Smart mesoporous silica nanoparticles for controlled-release drug delivery
    Karimi, Mahdi
    Mirshekari, Hamed
    Aliakbari, Masoumeh
    Sahandi-Zangabad, Parham
    Hamblin, Michael R.
    NANOTECHNOLOGY REVIEWS, 2016, 5 (02) : 195 - 207
  • [23] Polymer coated mesoporous silica nanoparticles controlled by nanovalves for drug delivery
    Dong, Juyao
    Xue, Min
    Zink, Jeffrey I.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [24] Mesoporous silica nanoparticles: Synthesis and multifaceted functionalization for controlled drug delivery
    Gupta, Jayesh
    Quadros, Mural
    Momin, Munira
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 81
  • [25] Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
    Iturrioz-Rodriguez, Nerea
    Correa-Duarte, Miguel A.
    Fanarraga, Monica L.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 : 3389 - 3401
  • [26] Hollow silica-polyelectrolyte composite nanoparticles for controlled drug delivery
    Yang, Qingsong
    Li, Li
    Zhao, Fang
    Han, Haoya
    Wang, Weihua
    Tian, Yuchuan
    Wang, Yunwei
    Ye, Zhishuang
    Guo, Xuhong
    JOURNAL OF MATERIALS SCIENCE, 2019, 54 (03) : 2552 - 2565
  • [27] Integrated Hollow Mesoporous Silica Nanoparticles for Target Drug/siRNA Co-Delivery
    Ma, Xing
    Zhao, Yun
    Ng, Kee Woei
    Zhao, Yanli
    CHEMISTRY-A EUROPEAN JOURNAL, 2013, 19 (46) : 15593 - 15603
  • [28] A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application
    Teng, Xu
    Cheng, Shan
    Meng, Ran
    Zheng, Shuai
    Yang, Longyan
    Ma, Qian
    Jiang, Wenguo
    He, Junqi
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2015, 15 (05) : 3773 - 3779
  • [29] Mesoporous silica nanoparticles for drug and gene delivery
    Zhou, Yixian
    Quan, Guilan
    Wu, Qiaoli
    Zhang, Xiaoxu
    Niu, Boyi
    Wu, Biyuan
    Huang, Ying
    Pan, Xin
    Wu, Chuanbin
    ACTA PHARMACEUTICA SINICA B, 2018, 8 (02) : 165 - 177
  • [30] Synthesis of Mesoporous Silica Nanoparticles for Drug Delivery
    Wu, Yazhen
    Jia, Xiaoyun
    Lin, Yuanhua
    Liu, Deping
    HIGH-PERFORMANCE CERAMICS VIII, 2014, 602-603 : 67 - 70